|
Drug Candidate for the Treatment of Dilated Cardiomyopathy
Invention Summary: Dilated cardiomyopathy (DCM) is the most common cause of heart failure. About 5.7 million adults in the United States have heart failure, and approximately half million new cases are diagnosed annually. Patients with DCM can lead to arrhythmias, and about half of people who develop heart failure die within 5 years of diagnosis. Current...
Published: 12/8/2021
|
Inventor(s): Diego Fraidenraich, Qingshi Zhao
Keywords(s): Cardiovascular, Peptides
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics
|
